<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: <z:hpo ids='HP_0000855'>Insulin resistance</z:hpo> (IR) and <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> may share a common genetic background </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated the role of IR-associated ENPP1 K121Q polymorphism (rs1044498) on <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> in high-risk individuals </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS: A prospective study (average follow-up, 37 months) was conducted for major cardiovascular events (<z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> [MI], <z:hpo ids='HP_0001297'>stroke</z:hpo>, cardiovascular <z:hpo ids='HP_0011420'>death</z:hpo>) from the Gargano Heart Study (GHS; n = 330 with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo>), the Tor Vergata <z:hpo ids='HP_0002621'>Atherosclerosis</z:hpo> Study (TVAS; n = 141 who had MI), and the Cardiovascular Risk Extended Evaluation in Dialysis (CREED) database (n = 266 with <z:hpo ids='HP_0003774'>end-stage renal disease</z:hpo>) </plain></SENT>
<SENT sid="3" pm="."><plain>Age at MI was investigated in cross-sectional studies of 339 type 2 diabetic patients (n = 169 from Italy, n = 170 from the U.S.) </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Incidence of cardiovascular events per 100 person--years was 4.2 in GHS, 10.8 in TVAS, and 11.7 in CREED </plain></SENT>
<SENT sid="5" pm="."><plain>Hazard ratios (HRs) for KQ+QQ versus individuals carrying the K121/K121 genotype (KK) individuals were 1.47 (95% CI 0.80-2.70) in GHS, 2.31 (95% CI 1.22-4.34) in TVAS, and 1.36 (95% CI 0.88-2.10) in CREED, and 1.56 (95% CI 1.15-2.12) in the three cohorts combined </plain></SENT>
<SENT sid="6" pm="."><plain>In the 395 diabetic patients, the Q121 variant predicted cardiovascular events among <z:mp ids='MP_0001261'>obese</z:mp> but not among nonobese individuals (HR 5.94 vs. 0.62, P = 0.003 for interaction) </plain></SENT>
<SENT sid="7" pm="."><plain>A similar synergism was observed in cross-sectional studies, with age at MI being 3 years younger in Q121 carriers than in KK homozygotes among <z:mp ids='MP_0001261'>obese</z:mp> but not among nonobese patients (P = 0.035 for interaction) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: The ENPP1 K121Q polymorphism is an independent predictor of major cardiovascular events in high-risk individuals </plain></SENT>
<SENT sid="9" pm="."><plain>In type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, this effect is exacerbated by <z:hpo ids='HP_0001513'>obesity</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>Future larger studies are needed to confirm our finding </plain></SENT>
</text></document>